
NVS News
Novartis AG
$150.47
-$0.75(-0.50%)
66
Overall
80
Value
58
Tech
60
Quality
Market Cap
$288.55B
Volume
2.24M
52W Range
$126.50 - $170.46
Target Price
$153.90
NVS news: the latest Novartis AG headlines, press releases and market updates, newest first.
Latest NVS News
- Citi Sticks to Its Buy Rating for Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Nov 21, 2026
- Goldman Sachs Sticks to Its Sell Rating for Novartis (NVS)TipRanks Auto-Generated Intelligence Newsdesk · Nov 20, 2026
- Barclays Remains a Hold on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Nov 20, 2026
- RBC Capital Sticks to Their Hold Rating for Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Nov 19, 2026
- Novartis Raises Peak-Sales Guidance for Three Key BrandsTipRanks Auto-Generated Newsdesk · Nov 19, 2026
- Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Azora Therapeutics (AZR)TipRanks Newsroom · Nov 17, 2026
- SCHD, VYMI, or VIG: Which Dividend ETF Fits In Your Portfolio?Kirti Tak · Nov 17, 2026
- Cineverse Earnings Call Highlights Growth and ProfitabilityTipRanks Auto-Generated Newsdesk · Nov 15, 2026
- Novartis AG (NOVN) Gets a Hold from BarclaysTipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- Envista Holdings (NVST) Gets a Buy from Stifel NicolausTipRanks Auto-Generated Intelligence Newsdesk · Nov 5, 2026
- Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), ACADIA Pharmaceuticals (ACAD) and Arcutis Biotherapeutics (ARQT)TipRanks Newsroom · Nov 5, 2026
- Annovis Bio Files Charter Amendment After Stockholder ApprovalTipRanks Auto-Generated Newsdesk · Nov 4, 2026
- Annovis Bio Clarifies Regulation FD Disclosure in Current ReportTipRanks Auto-Generated Newsdesk · Nov 4, 2026
- Novartis AG (NOVN) Gets a Buy from J.P. MorganTipRanks Auto-Generated Intelligence Newsdesk · Oct 29, 2026
- Citi Reaffirms Their Buy Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Novartis AG (NOVN) Receives a Hold from JefferiesTipRanks Auto-Generated Intelligence Newsdesk · Oct 27, 2026
- UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
- Novartis AG (NOVN) Gets a Hold from BarclaysTipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVS | $150.47 | -0.5% | 2.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |